Clinical trial

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD

NCT00741767

Study summary

ClinicalTrials.gov

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention salmeterol-fluticasone Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2008-08-01

PhaseNA

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Sleep Disordersunresolved

Interventions

salmeterol-fluticasoneDRUG

Sponsors & collaborators

Northwestern Universitylead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00741767 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.